Study Summary
The investigators will assess the use of Transcutaneous Neurostimulation (TENS), a pharmacological alternative, for treatment of ureteral stent pain post-ureteroscopy. The primary aim for the investigators is to determine if use of a TENS unit will reduce post-operative pain and nausea associated with the ureteral stent. Secondary aim will be to assess if it can help minimize narcotic use.
Eligible Conditions
- Kidney Stones
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 3-10 days
3-10 days
Pain on 11-point Visual Analog Score scale for each day until Ureteral Stent removed
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Standard care
1 of 2
TENS device
1 of 2
Active Control
Experimental Treatment
60 Total Participants · 2 Treatment Groups
Primary Treatment: TENS device · No Placebo Group · N/A
TENS device
Device
Experimental Group · 1 Intervention: TENS · Intervention Types: DeviceStandard careNoIntervention Group · 1 Intervention: Standard care · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TENS
2011
Completed Phase 2
~1990
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3-10 days
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,164 Previous Clinical Trials
35,687,688 Total Patients Enrolled
Simon Conti, MDPrincipal InvestigatorStanford University
Eligibility Criteria
Age 18 - 70 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:have a low but finite risk of developing a post-procedure ureteral complication
are 50% less likely to experience a complication than those not receiving a stent
Who else is applying?
What state do they live in?
| Pennsylvania | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 100.0% |
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments